Drug recall
Whole Blood, Leukocytes Reduced
FDA recall event 92227 · Class II · Carter BloodCare
Key facts
| Event ID | 92227 |
|---|---|
| Recall numbers | B-0411-2023 |
| Recalling firm | Carter BloodCare |
| Product type | Biologics |
| Products | Whole Blood, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced whole blood product, which failed to meet product specifications, was distributed. |
| Initiation date | Mar 24, 2023 |
| Report date | May 17, 2023 |
| Termination date | May 9, 2023 |
| City | Bedford |
| State | TX |
| Country | United States |
| FEI number | 3002603147 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: